Syndesmosis Implant Systems Market
Number of pages: 100 | Report Format: PDF | Published date: June 08, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 82.21 million |
|
Revenue Forecast in 2031 |
US$ 167.09 million |
|
CAGR |
8.20% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product Type, Application, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global syndesmosis implant systems market was valued at US$ 82.21 million in 2022 and is expected to register a revenue CAGR of 8.20% to reach US$ 167.09 million by 2031.
Syndesmosis Implant Systems Market Fundamentals
High ankle sprains, also known as syndesmosis injuries, can result in considerable discomfort and instability in the ankle area. The syndesmosis a fibrous joint that links the tibia and fibula bones in the lower leg, is often affected by these injuries. To promote the stabilization and recovery of syndesmosis injuries, implant systems for syndesmosis have emerged as a viable solution. These implant systems typically comprise screws, plates, and other fixation devices that assist in reestablishing the stability and positioning of the ankle joint.
Over the years, there has been an increasing need for syndesmosis implant systems due to increasing incidences of sports-related injuries and a greater focus on preserving joint function. Technological advancements and new implant designs have emerged that provide better biomechanical properties, such as improved load-bearing capacity and less stress on surrounding tissues. Additionally, the growing popularity of minimally invasive surgical approaches has further driven the demand for syndesmosis implant systems, as they enable faster recovery and better patient results.
Several top players are actively involved in developing and promoting syndesmosis implant systems. These companies are constantly investing in research and development to introduce advanced implant designs and materials that enhance surgical outcomes. They are also focusing on expanding their product portfolios to accommodate a wide range of patient needs. Additionally, market players are collaborating with orthopedic surgeons and medical institutions to conduct clinical trials and gather real-world data to validate the efficacy and safety of their implant systems. These initiatives aim to improve the overall patient experience and provide orthopedic surgeons with reliable solutions for syndesmosis injuries.
Syndesmosis Implant Systems Market Dynamics
The increasing prevalence of sport-related injuries is the key factor driving the global syndesmosis implant systems market. According to John Hopkins Medicine, over 30 million children and teens in the United States participate in organized sports. Unfortunately, each year, over 3.5 million injuries occur, causing participants to lose time in their sport. This trend is expected to increase in the coming years due to the increasing participation of individuals in sports activities.
Moreover, there have been significant improvements in syndesmosis implant systems that have led to better surgical methodologies and enhanced patient results. These implants are now constructed with more robust and long-lasting materials, such as titanium or cobalt chrome, that can efficiently endure the pressure exerted on the ankle joint during weight-bearing actions. For example, the use of a tightrope system for ankle syndesmosis injuries has become increasingly popular due to its minimally invasive approach and ability to provide stable fixation. This system involves placing a high-strength suture through the tibia and fibula bones, allowing for dynamic stabilization during weight-bearing activities.
The global market for syndesmosis implant systems is experiencing significant growth due to the increasing funding activities towards launching innovative products. Additionally, government initiatives in developing regions to enhance their healthcare infrastructure have increased the demand for syndesmosis repair systems globally. For instance, top market players such as Arthrex and Zimmer Biomet are investing heavily in research and development to develop advanced syndesmosis implant systems that offer improved patient outcomes. These innovations are expected to further fuel the revenue growth of the market in the coming years.
Syndesmosis injuries are quite common, yet there seems to be a lack of awareness among patients, healthcare professionals, and even some orthopedic surgeons about the advantages and accessibility of syndesmosis implant systems.
Syndesmosis Implant Systems Market Ecosystem
The global syndesmosis implant systems market is analyzed from three perspectives: product type, application, and region.
Syndesmosis Implant Systems Market by Product Type
Based on product type, the global syndesmosis implant systems market is segmented into biodegradable material-based implants, stainless steel-based plate implants, and titanium-based plate implants.
The titanium-based plate implants segment accounted for 55% of the global syndesmosis implant systems market revenue share in 2022. This is due to the increasing preference for titanium-based implants, which are durable, lightweight, and biocompatible. Moreover, titanium implants have a low incidence of complications such as infection, making them a popular choice among surgeons and patients. In addition, the growing incidence of ankle injuries and fractures is expected to drive the demand for syndesmosis implant systems, further boosting the market growth of titanium-based plate implants.
Syndesmosis implants made from biodegradable materials are used to augment syndesmosis implants, enhancing their durability and reducing the chances of infection. These implants are created using materials that naturally break down over time, leaving no residue behind. As a result, they pose a lower risk of irritation or other complications and can be removed without causing any harm to the adjacent tissue.
Syndesmosis Implant Systems Market by Indications
Based on the applications, the global syndesmosis implant systems market is segmented into ankle fractures, syndesmosis, and postoperative management.
The ankle fracture segment accounted for 53.7% of the global syndesmosis implant systems market. This is due to the high prevalence of ankle fractures, which are commonly caused by sports injuries, falls, and accidents. According to the National Center for Biotechnology Information, in May 2020, approximately 673,214 ankle fractures were reported with an incidence rate of 4.22/10,000 person-years. Additionally, the increasing incidences of osteoporosis, mostly in the elderly population have also contributed to the growth of the syndesmosis implant systems market for ankle fractures. The Office of Disease Prevention and Health Promotion reports that approximately 10 million individuals aged 50 or older in the United States suffer from osteoporosis, predominantly women but with a significant number of men - around 2 million. The market is expected to continue to grow in the coming years, with advancements in technology and increasing demand for minimally invasive procedures driving further adoption of these systems.
Syndesmosis Implant Systems Market by Region
Based on the region, the syndesmosis implant systems market is segmented into North America, Europe, Asia Pacific, Latin America, & the Middle East & Africa.
North America accounted majority of the global syndesmosis implant systems market, with the majority of market revenue share in 2022. This can be attributed to the increasing prevalence of age-related macular degeneration (AMD) and diabetic retinopathy (DR) in the region. According to the National Eye Institute, AMD is the leading cause of blindness among adults aged 50 and above in the United States. Similarly, the Centers for Disease Control and Prevention estimates that around 4.1 million adults in the US have diabetic retinopathy. Moreover, the presence of advanced healthcare standards is supporting the global syndesmosis implant systems market.
The syndesmosis implant systems market in Europe is expected to experience significant growth in the coming years. This can be attributed to the rising prevalence of sports injuries, the increasing geriatric population, and advancements in medical technology. Additionally, the growing adoption of minimally invasive surgeries and increasing awareness regarding the benefits of syndesmosis implant systems are expected to drive market revenue growth.
The Asia Pacific syndesmosis implant systems market is projected to show a significant growth of 8.8% CAGR in the forecast years. This growth can be attributed to the rising prevalence of ankle injuries and the increasing adoption of minimally invasive surgical procedures. As per the BMJ journal, it was found that women had an incidence rate of 1.9% per 3 months for foot and ankle injuries in 2021, while men had a higher rate of 3.2% per 3 months. Additionally, the growing geriatric population affected by osteoporosis and the rising number of sports injuries are expected to drive the demand for syndesmosis implant systems in the Asia Pacific region.
Syndesmosis Implant Systems Competitive Landscape
Some of the prominent companies having the largest revenue share in the global syndesmosis implant systems market are,
Strategic Development
The syndesmosis a fibrous joint that links the tibia and fibula bones in the lower leg - is often affected by these injuries. To promote the stabilization and recovery of syndesmosis injuries, implant systems for syndesmosis have emerged as a viable solution.
The global syndesmosis implant systems market has witnessed significant growth over the years. This can be attributed to the increasing prevalence of sports-related injuries, the rising geriatric population, and the growing demand for minimally invasive surgeries.
The global syndesmosis implant systems market is expected to register a revenue CAGR of 8.20% in the forecast period from 2022 to 2031.
North America region dominated the global syndesmosis implant systems market in 2022.
The global syndesmosis implant systems market was valued at US$ 82.21 million in 2022.
*Insights on financial performance are subject to the availability of information in the public domain